OAM
ELV icon

Ostrum Asset Management’s Elevance Health ELV Stock Holding History

Ostrum Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Buy
7,485
+120
+2% +$44.5K 0.14% 105
2026
Q1 		$2.16M Sell
7,365
-613
-8% -$201K 0.12% 133
2025
Q4 		$2.8M Sell
7,978
-1,529
-16% -$517K 0.13% 122
2025
Q3 		$3.07M Sell
9,507
-6,673
-41% -$2.08M 0.14% 135
2025
Q2 		$6.29M Buy
16,180
+5,340
+49% +$2.15M 0.29% 56
2025
Q1 		$4.71M Buy
10,840
+6
+0.1% +$2.41K 0.25% 66
2024
Q4 		$4M Sell
10,834
-320
-3% -$134K 0.35% 67
2024
Q3 		$5.8M Sell
11,154
-210
-2% -$112K 0.48% 38
2024
Q2 		$6.16M Sell
11,364
-1,110
-9% -$587K 0.54% 30
2024
Q1 		$6.47M Buy
12,474
+523
+4% +$260K 0.51% 27
2023
Q4 		$5.64M Sell
11,951
-272
-2% -$126K 0.49% 38
2023
Q3 		$5.32M Sell
12,223
-29
-0.2% -$13.2K 0.49% 33
2023
Q2 		$5.44M Sell
12,252
-216
-2% -$99.6K 0.46% 47
2023
Q1 		$5.73M Buy
+12,468
New +$5.93M 0.5% 37

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ostrum Asset Management's ELV Position: Q2 2026 in Review

Ostrum Asset Management increased its Elevance Health (ELV) stake by 1.6% in Q2 2026, buying an estimated $44.5K and bringing the position to 7,485 shares worth $2.89M. The position accounts for 0.14% of the portfolio, ranked #105.

Ostrum Asset Management first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.47M in Q1 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ostrum Asset Management held 7,485 shares of Elevance Health worth $2.89M as of Q2 2026.
  • Ostrum Asset Management bought 120 Elevance Health shares in Q2 2026, an estimated $44.5K.
  • Elevance Health made up 0.14% of Ostrum Asset Management's portfolio in Q2 2026, its #105 holding.
  • Ostrum Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Ostrum Asset Management's Elevance Health position peaked at $6.47M in Q1 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.